ADHERENCE TO NEBULISED THERAPIES IN PEOPLE WITH CYSTIC FIBROSIS STARTING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR (KAFTRIO)

被引：1
|
作者：
Howell, I. B. [1 ]
Tugwell, A. [1 ]
Bhaskaran, D. [1 ]
Bell, N. J. [1 ]
机构：
[1] Bristol Adult Cyst Fibrosis Ctr, Bristol, Avon, England
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2021-BTSabstracts.65
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S59
引用
收藏
页码：A40 / A40
页数：1
相关论文
共 50 条
  • [1] Research letter: The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis
    Song, Jia Tong
    Desai, Sameer
    Franciosi, Alessandro N.
    Dagenais, Renee V. E.
    Quon, Bradley S.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (06) : 1080 - 1081
  • [2] Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
    Salehi, Mahan
    Iqbal, Mubashar
    Dube, Asha
    AlJoudeh, Amer
    Edenborough, Frank
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [3] Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
    Nichols, David P.
    Paynter, Alex C.
    Heltshe, Sonya L.
    Donaldson, Scott H.
    Frederick, Carla A.
    Freedman, Steven D.
    Gelfond, Daniel
    Hoffman, Lucas R.
    Kelly, Andrea
    Narkewicz, Michael R.
    Pittman, Jessica E.
    Ratjen, Felix
    Rosenfeld, Margaret
    Sagel, Scott D.
    Schwarzenberg, Sarah Jane
    Singh, Pradeep K.
    Solomon, George M.
    Stalvey, Michael S.
    Clancy, John P.
    Kirby, Shannon
    Van Dalfsen, Jill M.
    Kloster, Margaret H.
    Rowe, Steven M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (05) : 529 - 539
  • [4] Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations
    Fainardi, Valentina
    Cresta, Federico
    Sorio, Claudio
    Melotti, Paola
    Pesce, Emanuela
    Deolmi, Michela
    Longo, Francesco
    Karina, Kleinfelder
    Esposito, Susanna
    Pisi, Giovanna
    [J]. PEDIATRIC PULMONOLOGY, 2024,
  • [5] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [6] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    [J]. PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [7] Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis
    Beck, Michael R.
    Hornick, Douglas B.
    Pena, Tahuanty A.
    Singh, Sachinkumar B.
    Wright, Brittany A.
    [J]. PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1569 - 1573
  • [8] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [9] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
    Smith, Megan
    Ryan, Kevin J.
    Gutierrez, Hector
    Sanchez, Luz Helena Gutierrez
    Anderson, Janaina Nogueira
    Acosta, Edward P.
    Benner, Kim W.
    Guimbellot, Jennifer S.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
  • [10] Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
    Gramegna, Andrea
    Majo, Fabio
    Alicandro, Gianfranco
    Leonardi, Gloria
    Cristiani, Luca
    Amati, Francesco
    Contarini, Martina
    Aliberti, Stefano
    Fiocchi, Alessandro Giovanni
    Blasi, Francesco
    [J]. RESPIRATORY RESEARCH, 2023, 24 (01)
12345